European Archives - Page 43 of 1261 - European Medical Journal

Older Women Report Sexual Dysfunction but Less Distress, Study Finds

A study of over 3,400 women aged 50+ found that while sexual dysfunction was common in both midlife and older women, those aged 65 and above reported less distress, suggesting shifting expectations and perceptions with age.

PD-1 Inhibitors Plus Chemotherapy Show Promise in Advanced Gastric Cancer

A new study finds that PD-1 inhibitors combined with chemotherapy achieved a 97.7% disease control rate and median progression-free survival of 13.5 months in advanced gastric cancer patients.

Could Low Vitamin D Increase Thyroid Cancer Risk?

Lower vitamin D levels linked to higher thyroid cancer risk, new meta-analysis suggests clinical importance.

Faecal Microbiota Transplant Beats Antibiotics in Recurrent C. difficile

FMT and microbiome therapies significantly outperform antibiotics in recurrent C. difficile infection, with cure rates up to 91% and favourable long-term safety.

British government buildings

UK government establishes RNA Biofoundry

A £29.6 million government investment will establish the UK RNA Biofoundry in Darlington, providing manufacturing capacity to accelerate RNA therapies from lab to clinic.

New AI System Boosts Accuracy in Skin Cancer Diagnosis

Clinical examination is limited by visual similarity between benign and malignant lesions and imperfect diagnostic accuracy.

EMJ Neurology 13 [Supplement 8] 2025

In this article, Ana Suller-Marti, Associate Professor of Neurology, Western University, London, Canada; James Wheless, Professor and…

Optimising CAR-T Cell Therapy in RRMM

The ‘Mastering the Relapsed Refractory Multiple Myeloma (RRMM) Treatment Landscape: Removing Barriers and Unleashing the Potential of…

Evidence on VNS in the Modern DRE Treatment Landscape

Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…

Patient-Reported Outcome Measures, 1 Year After COVID-19

Learn more about the long-term health effects persisting one year after COVID-19 infection, including fatigue, breathlessness…